Effects of Sleep Loss on Endothelial Function and Cytokine Levels in Internal Medicine Residents
NCT ID: NCT00272233
Last Updated: 2007-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
22 participants
OBSERVATIONAL
2004-12-31
2005-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physiologic Effects of Sleep Restriction
NCT01433315
Repeated Challenge of Insufficient Sleep: Endothelial Effects
NCT01523535
Effect of Total Sleep Deprivation on Vascular Function
NCT04535219
Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
NCT05775731
Effects of Chronic Insomnia on the Neuroendocrine Regulation of Glucose and Lipid Metabolism
NCT00442624
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective: We sought to test the hypothesis that sleep loss during extended work shifts during medical training is associated with increased circulating levels of pro-inflammatory biomarkers and evidence of vascular dysfunction.
Design: Outcome measures were assessed after extended 30-hour work shifts and non-extended 6-hour work shifts in a single-blind, randomized crossover design.
Setting: University hospital medical intensive care unit
Patients or Other Participants: Twenty-two healthy medical residents were studied during a medical intensive care unit rotation.
Main Outcome Measure(s): Sleep related cytokines (interleukin-6 and tumor necrosis factor), serum markers of vascular inflammation (C-reactive protein), and flow-mediated dilation in the brachial artery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
DEFINED_POPULATION
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-smoker
* Body mass index \<28 kg/m2
Exclusion Criteria
* Known history of diabetes mellitus, hypertension, hyperlipidemia
* Known history of acute or chronic inflammatory or infectious disease
* Known history of sleep disturbance unrelated to work
* Pregnancy
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
National Center for Research Resources (NCRR)
NIH
Yale University
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stuart D Katz, MD
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale University School of Medicine
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIH NHLBI K24 04024
Identifier Type: -
Identifier Source: secondary_id
HIC26414
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.